Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mounjaro
Biotech
Lilly's next focus: Testing incretins in neuro, immunology fields
“We'll be prepared to move rapidly into phase 3 trials based on clinical data and where our conviction is high,” Lilly's CSO Daniel Skovronsky said.
Gabrielle Masson
Feb 6, 2025 2:35pm
The most valuable R&D projects? You guessed it: obesity
Jul 11, 2024 5:00am
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
Lilly uses Mounjaro millions to hunt for biotech partners
May 1, 2024 9:26am
Lilly's obesity portfolio in 'all-of-the-above mode'
Nov 2, 2023 11:15am
Lilly, BioAge to test muscle regeneration drug with tirzepatide
Oct 26, 2023 11:39am
